NAOV — NanoVibronix Cashflow Statement
0.000.00%
Last trade - 00:00- $3.26m
- $2.51m
- $2.56m
- 32
- 24
- 31
- 18
Annual cashflow statement for NanoVibronix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.33 | -14.3 | -5.45 | -3.71 | -3.71 |
| Depreciation | |||||
| Non-Cash Items | 0.487 | 10.4 | 0.717 | 0.43 | 0.457 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.445 | -0.494 | -2.31 | -0.322 | 0.731 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.39 | -4.37 | -7.04 | -3.6 | -2.52 |
| Capital Expenditures | -0.002 | -0.003 | -0.003 | -0.001 | -0.003 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.002 | -0.003 | -0.003 | -0.001 | -0.003 |
| Financing Cash Flow Items | — | -0.388 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.52 | 4.58 | 2.09 | 4.22 | 0.001 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.2 | 0.204 | -5.02 | 0.57 | -2.53 |